HR 2605 · 109th Congress · Foreign Trade and International Finance

To suspend temporarily the duty on Formulations of Difenoconazole/Mefenoxam.

Introduced 2005-05-24· Sponsored by Rep. Terry, Lee [R-NE-2]· House

Bill Progress

✓
Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Trade.(2005-06-01)

Plain Language Summary

[AI summary unavailable — showing source text] Amends the Harmonized Tariff Schedule of the United States to suspend, through December 31, 2008, the duty on certain Formulations of Difenoconazole and Mefenoxam which contain Difenoconazole Technical 1H-1,2,4-triazole, 1-[[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl]methyl]- and Mefenoxam Technical (R,S)-2-[(2,6-dimethylphenyl]-methoxyacetylamino]-propionic acid methyl ester.…

Summarized by Claude AI · Non-partisan · For informational purposes only